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
 
Biofluids, such as serum and plasma, represent an ideal medium for the diagnosis of disease 
due to their ease of collection, that can be performed worldwide, and their fundamental 
involvement in human function.  The ability to diagnose disease rapidly with high sensitivity 
and specificity is essential to exploit advances in new treatments, in addition the ability to 
rapidly profile disease without the need for large scale medical equipment (e.g. MRI, CT) 
would enable closer patient monitoring with reductions in mortality and morbidity. Due to 
these reasons vibrational spectroscopy has been investigated as a diagnostic tool and has 
shown great promise for serum spectroscopic diagnostics. However, the optimum sample 
preparation, optimum sampling mode and the effect of sample preparation on the serum 
spectrum are unknown. This paper examines repeatability and reproducibility of attenuated 
total reflection (ATR) compared to transmission sampling modes and their associated serum 
sample preparation with spectral standard deviation of 0.0015 (post pre1processing) achievable 
for both sampling modes proving the collection of robust spectra. In addition this paper 
investigates the optimum serum sample dilution factor for use in high throughput transmission 
mode analysis with a 31fold dilution proving optimum and shows the use of ATR and 
transmission mode spectroscopy to illuminate similar discriminatory differences in a patient 
study. These fundamental studies provide proof of robust spectral collection that will be 
required to enable clinical translation of serum spectroscopic diagnostics. 
 
	



Rapid detection of diseases enables the early administration of a therapeutic strategy when the 
treatment is most effective, thus saving health expenditure and lives. For this purpose Fourier 
Transform Infrared (FTIR) spectroscopy is a suitable technique as it is non1destructive, label1
free, rapid, cost1effective, easy to operate and requires simple sample preparation. Moreover, 
the use of serum spectroscopy for diagnostics has the advantage for patients to be relatively 
non1invasive compared to current diagnostic methodologies such as biopsies. 
 
Over the past few years many studies have shown the successful use of vibrational 
spectroscopy for the analysis of biological samples.
1,2
 Recent studies have investigated the 
potential of vibrational spectroscopy as a diagnostic tool for the analysis of biofluids. A pilot 
study on saliva using FTIR spectroscopy associated with linear discriminant analysis (LDA), 
has reported the correct classification of diabetic patients from healthy control (overall 
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accuracy of 100% on the training set and 88.2% on the validation test).
3
 The potential of 
human tears for the diagnosis of ocular diseases has been evaluated in preliminary studies, 
Travo  have shown significant discrimination (p<0.0001) of healthy people from patients 
with keratoconus (degenerative disorder affecting the cornea) and also between patients at an 
early or advanced stage of disease by high throughput (HT)1FTIR and principal component 
analysis (PCA).416 A study on synovial fluid by Raman spectroscopy and k1means analysis, has 
shown the discrimination of patients with osteoarthritis of low or high severity (74% sensitivity 
and 71% selectivity).7 Bile patient samples with malignant biliary strictures were differentiated 
from samples of patients with benign biliary diseases (sensitivity between 82% and 95%, 
specificity between 85% and 100%) by HT1FTIR spectroscopy in association with support 
vector machine (SVM) classification and leave1one1out cross validation (LOOVC).
8
 A Raman 
analysis combined with PCA and quadratic discriminant analysis (QDA) performed on urine 
has allowed the discrimination of patients suffering from diabetes mellitus and hypertension 
with low, high risk of kidney failure or with kidney failure (under dialysis) with a 70% overall 
classification rate (89% for the control group and 81% for both high risk and renal failure 
groups).9 However, the most popular biofluids analysed by vibrational spectroscopy are blood1
derived products such as plasma
10114
 and serum.
15118 
Proof1of1principle studies have shown the 
ability of FTIR spectroscopy to identify different types of cancer from serum samples. HT1
FTIR spectroscopy in transmission mode, was used to discriminate urinary bladder cancer 
patients from patients with urinary tract infection with an accuracy between 85 and 92% 
achieved with LDA or random forest (RF) classifier,
19
 breast cancer from healthy donors with 
96% sensitivity and 93% specificity with cluster analysis,20 cirrhotic patients with or without 
hepatocellular carcinoma with 87% sensitivity and 85% specificity by SVM1LOOCV.
21 
Studies 
using attenuated total reflection (ATR)1FTIR spectroscopy, coupled with classification 
machine analysis obtained an accuracy of 95% and 82% for the discrimination of ovarian and 
endometrial cancer 22 and allowed to achieve 87.5% sensitivity and 100 % specificity for the 
differentiation of glioblastoma multiforme (GBM) 	
	 healthy control as well as on average 
of 94% sensitivity and 96.5% specificity for the diagnosis of low grade gliomas, GBM and
healthy control.
23,24 
 
Vibrational spectroscopy provides information on the composition and structure of matter. The 
principle of IR spectroscopy is based on the interaction of IR light with matter. Molecular 
bonds absorb the IR radiation at the resonant frequency of the bond or group, exciting 
vibrational modes. The resultant spectrum is a biochemical fingerprint of the analysed sample, 
each absorption peak/band corresponds to a specific vibration or combination of vibrations of a 
molecular bond. This absorption phenomenon obeys the Beer1Lambert law, thus allowing to 
obtain both quantitative and qualitative information.25 In order to realise the full potential of IR 
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spectroscopy as a leading healthcare tool, some issues need to be understood prior to clinical 
translation.26 One issue in particular related to biofluid spectroscopy is due to the strong IR 
activity of water. As such, the most common protocol for analysing liquids such as biofluids is 
the drying of drop deposits. However, it has been shown by optical and spectroscopic 
assessment that this deposition is not homogenous. 
27131 
Thus, reproducibility and reliability of 
drop1dried spectroscopic results are still questioned. This is even more pronounced when using 
microspectroscopy. In addition, when analysing biofluids with IR transmission mode it is 
common to dilute the sample, due to saturation of spectral peaks, with water prior to drying. 
The effect upon the spectrum and the optimum dilution is unknown and has not been 
previously investigated. In order to take full advantage of the potential of biofluid spectroscopy 
to provide a rapid and responsive diagnostic environment, this study reports the use of HT1
FTIR, FTIR imaging and ATR1FTIR to investigate and understand the effect of sample 
preparation upon the IR spectrum and provide an optimum sample preparation for biofluid 
spectroscopy.  
 


 

 
Normal human mixed pooled serum purchased from TCS Biosciences (UK) were used for 
dilution tests. Serum samples (n=105) from 70 patients needing high risk surgery (e.g. liver 
and renal surgery, lung resection, large bowel resection, gastrectomy, Whipple’s procedure) 
were provided by the Defence Science & Technology Laboratory (Dstl) Porton Down. The 
study has been approved by Southampton & South West Hampshire Research Ethics 
Committee (A), 1st Floor, Regents Park Surgery, Shirley, Southampton, Hants, SO16 4RJ 
(reference number 06/Q1702/152). A consent form was signed by all patients recruited into the 
study at the medical care centres  involved (Liverpool Royal and University Hospital, 
University College Hospital, London, Bristol Royal Infirmary, Guy’s & St Thomas’ Hospital, 
London, Birmingham Queen Elizabeth Hospital and University Hospital, Frankfurt). Clotted 
blood samples (4mL) were centrifuged and the extracted serum samples were stored at 180°C 
until needed for analysis. The serum collected include 35 pre1operative samples, 35 post1
operative samples from the same patients the day following surgery and 35 additional pre1
operative samples from different patients. The study included 35 males and 32 females (the 
gender of 3 patients from records were not provided) between 21 and 79 years old with an 
average age of 60 years. 
 

	
		

$Q
DO\
WLF
DO
0H
WKR
GV
$F
FH
SWH
G0
DQ
XV
FUL
SW
Pu
bl
ish
ed
 o
n 
23
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
tra
th
cl
yd
e o
n 
30
/0
3/
20
15
 1
5:
51
:0
4.
 
 Four dilutions (1/2, 1/3, 1/4, 1/5) were performed on normal pooled serum with physiological 
water (NaCl 0.9%, same salinity as blood and used for intravenous injection and dilution of 
drugs purchased from B. Braun, France). Five microliters per replicate and 10 replicates per 
sample including diluted, non1diluted normal serum and physiological water as control, were 
pipetted onto each well of a silicon plate (384 wells). Drops were dried at room temperature 
before the spectral data acquisition. Serum samples from patients were 31fold diluted and 8 
replicates were prepared using the same protocol. 
 
	

	

 
Spectra of diluted, non1diluted pooled serum, physiological water (30 spectra per condition, 
180 spectra in total) and patient serum samples (840 spectra in total) were collected with a 
high1throughput screening HTS1XT extension coupled to a Tensor 27 spectrometer (both from 
Bruker Optics GmbH, Ettlingen, Germany). Spectral acquisition was performed in the 
transmission mode, controlled via OPUS v6.5 software (Bruker Optics GmbH, Ettlingen, 
Germany) and collected at a spectral resolution of 4 cm
11
, co1adding 32 scans over the spectral 
range of 40001400 cm11. A background spectrum was acquired before each sample 
measurement and automatically removed from sample spectra. One spectrum is obtained over 
the whole surface of a well (~4 mm diameter) of the 384 well silicon plate used in the HTS1XT 
extension. 
 
To study the drop heterogeneity, spectral images of the diluted serum drops were acquired with 
a PerkinElmer Spectrum Spotlight 400 imaging system (Courtaboeuf, France). Three spectral 
images were performed on non1diluted, diluted pooled serum and physiological water (18 
spectral images in total) at a spatial resolution of 25 µm/pixel, a spectral resolution of 4 cm11, 8 
co1added scans, and covering the spectral range of 40001750 cm11 (Spectrum1Image software, 
version 1.6, PerkinElmer). 
 
Patient serum sample spectra were also collected using a Cary 600 series FTIR spectrometer 
from Agilent technologies, USA, equipped with a Pike Miracle ATR Accessory. After 
thawing, 1µL of each sample was pipetted onto a germanium (Ge) crystal and dried for 8 
minutes at room temperature. Three spectra were collected per biological replicate and 3 
replicates performed for each sample (9 spectra per patient sample and 945 spectra for all 
samples in total). Spectra were acquired at a resolution of 4 cm−1, over the spectral range of 
40001400 cm
−1
 and averaged over 32 co1added scans (Agilent software, Agilent technologies, 
USA). A background absorption spectrum of the crystal was measured for atmospheric 
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correction before each replicate sample analysis and removed automatically from every sample 
spectrum. One average spectrum is obtained over the whole surface of the ATR crystal in 
contact with a sample. The crystal was washed between each replicate analysis. Experimental 
processes are detailed in the experimental schematic shown in Figure 1.  
 




 
A quality test as previously described21 was performed on raw spectra to control absorbance 
intensity, signal1to1noise ratio and water vapour content (OPUS v6.5 software, Bruker Optics 
GmbH, Ettlingen, Germany). Spectra with a maximum absorbance higher than 1.8 or lower 
than 0.35 in arbitrary units (a.u.) were rejected. Signal1to1noise ratio was calculated taking the 
maximum absorbance of the amide I band between 1700 and 1600 cm−1 (S1) and between 
1260 and 1170 cm
−1 
(S2) respectively divided by the noise intensity evaluated between 21001
2000 cm−1 (N). Spectra were rejected when S1/N was less than 50 and S2/N was less than 10. 
Water vapour content (W) was evaluated between the 184711837 cm
−1
. Spectra were rejected 
when S1/W was less than 20 and S2/W was less than 4. 
 
Following the quality test, data reproducibility was assessed on both raw and pre1processed 
spectra of diluted normal pooled serum via a variance study which consists in calculating the 
mean spectrum and the standard deviation (STD) for each sample dilution condition (Fig. 2). 
Pre1processing of HT1FTIR serum dilution test spectra was performed with OPUS v6.5 
software (Bruker Optics GmbH, Ettlingen, Germany). Spectra were cut to the spectral range of 
40001900 cm
11
, base1line corrected and vector normalised. 
 
Spectral images of serum drops were first subjected to an atmospheric correction for water 
vapour and C02 by the built1in Spectrum1Image software V1.6 (PerkinElmer, Les Ulis, France) 
of the Spotlight 400 imaging system. Spectral images were then reconstructed, based on a 
specific chosen single wavenumber in order to study the wavenumber1related component 
distribution within drops (Spectrum1Image V1.6). 
 
HT1FTIR and ATR1FTIR patient data pre1processing and multivariate analysis were realised 
with Matlab software version 7.11.0 (The Math Works, Inc., USA). All spectra were cut to the 
spectral range of 18001900 cm11 (fingerprint region). A principal component based noise 
reduction using the first 30 principal components (PCs) of the data was performed on the 
spectra to improve the signal1to1noise ratio. All spectra were then base1line corrected and 
vector normalised. Principal Component1Discriminant Function Analysis (PC1DFA) was 
performed on pre1processed data over the spectral region of 12001950 cm11. 
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Four dilutions (21fold, 31fold, 41fold and 51fold) of serum samples were prepared with 
physiological water in order to determine the most appropriate dilution for spectral acquisition 
with HT1FTIR spectroscopy as resulting spectra of non1diluted serum samples were saturated 
(Figure 2) at the protein Amide I and Amide II bands (170011500 cm11) and H1O1H stretching 
band at 3280 cm
11
. In the 21fold dilution sample group, 60% of the raw spectra failed the 
quality test, mainly due to a high maximum absorbance (> 1.8 a.u.) observed in the Amide I 
band. On the contrary with a 51fold dilution, 10% of the spectra were rejected because of a too 
low maximum absorbance (<0.35 a.u.) of the Amide I band. With the 31 and 41 fold dilution, 
all spectra passed the quality test with a maximum absorbance of 1.6 and 0.9 respectively.  
 
A variance study on both raw spectra and pre1processed spectra was carried out on the spectra 
that passed the quality test. Standard deviations (STD) of spectra from each dilution (raw and 
pre1processed) are reported in Table 1. Pre1processed spectra presented a lowest average STD 
compared to their corresponding raw data (Fig. 3). The pre1processing has improved the 
reproducibility of the spectra. The 21fold diluted pre1processed spectra showed the lowest 
average STD due to the low number of remaining spectra after the quality test (40%). The 51
fold diluted pre1processed spectra presented the highest average STD (0.0022). The STD 
results of the 3 and 4 fold dilution are similar with both providing low average STD after pre1
processing (0.0012 and 0.0013 respectively). Globally, the results show a good reproducibility 
of the spectra, similar to the reproducibility of human pooled serum spectra reported by Hands 
  via ATR1FTIR spectroscopy (average STD of 0.0137 and 0.0015 for raw and pre1
processed spectra respectively).
24 
 
Combining the quality test and the variance study results, the 31fold dilution was determined as 
the most suitable dilution for a serum HT1FTIR analysis with a good reproducibility and 
absorbance intensity. The 31fold dilution was chosen as a higher dilution (e.g. 41fold) will 
induce the risk of a low spectral response, especially for the analysis of molecules present at a 
low concentration within the serum. No molecular changes were visible on collected spectra, 
assuming that there was no effect of the dilution with water on the composition of the serum. 
Similar observations have been reported in a study by Raman spectroscopy on plasma dilution 
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tests. They concluded that the plasma dilution did not affect the chemical composition and 
molecular structure of proteins within dried drops.30 
 
 
Spectral images were acquired to better understand the distribution of serum molecular 
components within dried drops as physical differences were observed between non1diluted 
(presence of cracks) and diluted serum samples (hollow shape) suggesting a drop composition 
heterogeneity (white light images Figure 4). It can be seen on the total absorbance spectral 
image of the droplets that the absorbance intensity varies within the same drop, with a highest 
absorbance intensity in the drop edge compared to the centre. This translates as a concentration 
gradient of serum components from the centre to the periphery of the drops, showing an 
uneven drying process across the serum droplets. As expected a global absorbance intensity 
decrease was observed for diluted samples compared to non1diluted samples (total absorbance 
spectral images Figure 4). Spectral images based on a single wavenumber reconstruction 
enabled the determination, within a drop, of the distribution of molecules associated with the 
targeted peak. It was observed (reconstructed spectral images Figure 4) that serum components 
such as proteins (Amide I and Amide II bands around 1647 cm11 and 1542 cm11), lipids (1442 
cm
11
) and nucleic acids (1078 cm
11
) have a tendency to migrate towards the periphery of the 
drops. This phenomenon is referenced in the literature as the well1known coffee1ring effect.32134 
This effect was more visible when the dilution factor increased, the ring appearing thinner at 
the drops’ edges and the centres appearing more hollowed compared to non1diluted serum 
samples (white light images Figure 4). The deposit and the resulting drop morphology has also 
been shown to be influenced by the substrate hydrophobicity but without impact on the 
chemical composition of samples.
30 
To avoid the coffee1ring effect, a study has recommended 
to perform an analysis on a film composed of reduced1size drops (217 drops of 200 pL each 
per well of a 384 wells silicon plate) obtained by an automatic sampling and by controlling the 
drying process (vacuum drying). They obtained a higher reproducibility of spectral data 
compared to a non1automatic sampling.35 
 
The presence of cracks has been observed on non1diluted sample drops and was less 
visible/absent on diluted samples (white light images Figure 4). It has been reported that 
spectra acquired from sample areas containing cracks suffer from spectral distortions resulting 
in an abnormal Amide I and II bands and baseline.
29
 In this study, the dilution of the serum 
samples has provided visually a dried drop with greater homogeneity over the surface. 
Moreover, one averaged spectrum is acquired on the whole surface of a well with the HT1FTIR 
technique, resulting in a representative spectrum of the entire serum sample contrary to spectra 
collected in a single point mode as serum dried drops spectra have shown spatial but also 
chemical heterogeneity.28  
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An analysis was carried out on pre1 and post1operative serum samples from patients having 
undergone surgery for different clinical reasons. This set of samples (n=105) was used to 
compare the two techniques ATR1FTIR and HT1FTIR spectroscopy and also to enable the 
profiling of a baseline IR response when considering only surgery. ATR1FTIR is an excellent 
technique for the analysis of serum since a sample can be directly deposited and dried on the 
ATR crystal before the spectral acquisition.
36
 However, there are currently no multi1well 
sample accessories to enable rapid automated collection of spectra. HT1FTIR enables the rapid 
automated collection of spectra but there is an increased requirement for further sample 
preparation via sample dilution. As such it takes 6 hours to collect 360 spectra from 360 
samples on a multi1well plate via HT1FTIR spectroscopy and in the same amount of time 40 
spectra would have been able to be collected via the current ATR1FTIR approach (the addition 
sample preparation time for the HT1FTIR takes approximately 1 hour for the deposit of 360 
samples and 30 minutes for the samples drying). The sample preparation regarding the analysis 
of serum by ATR1FTIR has been reproduced from the methodology applied by Hands .
24
 
They have determined that a serum drop of 1µL is dry after 8 minutes at room temperature and 
that the resultant spectra acquired exhibited a high reproducibility. In the present study, spectra 
from human serum samples were collected from 1µL and 5µL (31fold diluted serum) for the 
ATR1FTIR and HT1FTIR spectroscopy respectively. These spectra were reproducible and 
repeatable thus conserving the serum resource by using minute amounts. Spectral differences 
are visible on the average spectra of the two pre1 and post1operative sample groups especially 
between 950 and 1200 cm11 for both ATR1FTIR and HT1FTIR techniques, further differences 
are discernable between 1250 and 1700 cm
11 
but only with the ATR1FTIR method (Figures 5A 
and 5D). A different ratio and a peak shift is observable for the Amide I and Amide II peaks 
between ATR and transmission sampling modes (Figures 5A, 5D and 5G). This is similar to 
the ratio and peak shift differences observed by Ollesch  
35
 on dried serum sample 
comparison between ATR and transmission due to dispersion effects.  Associated with PC1
DFA, both ATR1FTIR and HT1FTIR spectroscopies show similar scores plots and 
discriminatory ability to separate serum spectra over the range of 12001950 cm11 of patients 
prior to surgery and serum spectra after surgery in spite of similarities resulting in an overlap. 
Discriminant Function 1 (DF1) in both cases is responsible for the separation of the two 
spectral groups (Figures 5B and 5E) and DF2 is only shown for visual purposes. Loadings on 
DF1 contain only the spectral information that is responsible for the discrimination between 
spectral groups (Figure 5C and 5F). With both techniques, the same peaks have been identified 
but have opposite directions on the loadings plots. Positive peaks in DF1 loadings for the 
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ATR1FTIR spectroscopy analysis are negative in the DF1 loadings for the HT1FTIR 
spectroscopy study and vice versa. Spectra from the two groups are also separated in an 
inverse way against the 1axis of the scatter plots between the two techniques. Proposed peaks 
assignments are presented in Table 2. Major peaks of the loadings on DF1 were in both cases 
104011023 cm
11
 corresponding to glycogen and 1078 cm
11
 assigned as C–O stretch 
(DNA/RNA). It can be noted that a complete separation of the two groups by PC1DFA was not 
expected since it is known that a surgical procedure triggered physiological and immunological 
reactions in order to maintain the body homeostasis but the stress induced by surgery and the 
associated body responses are dependent of many factors such as the kind of procedure and its 
relative injury severity, pre1existing pathologies, genetic predisposition of patients and the 
difference observed will not be as significant as diseased versus non1diseased patient 
samples.37139 
 
!



HT1FTIR and ATR1FTIR techniques have both shown promising results for serum dried1drops 
analysis with a high reproducibility of the spectra collected on normal human pooled mixed 
serum samples. Moreover, both approaches associated with multivariate analysis have shown 
an equivalent capability to distinguish spectra of patient serum collected before and after 
surgical procedures. This base IR response to surgery should be taken into consideration when 
performing a diagnostic study as molecular changes observed in spectra might be due to the 
surgery / inflammation itself and not to the pathology targeted, however this study has shown 
that these responses are not significant enough to enable full differentiation of serum samples. 
Compared to the HT1FTIR technique where serum samples have to be diluted because of a 
saturation effect, with the ATR1FTIR method, samples can be directly applied onto the ATR 
crystal and can be portable. However, this implies no possible sample storage for further 
analysis as the crystal has to be cleaned after each sample measurement and no automation of 
the analysis is yet available. Regarding these aspects, with the HT1FTIR technique the storage 
of samples is in theory feasible but no studies have investigated the effect of the conservation 
over the time of serum properties integrity. A 31fold dilution was shown to be optimum based 
upon a variance study, quality test and the ability to detect low concentration biochemicals 
present compared to higher dilutions and is the recommendation for HT1FTIR analysis. HT1
FTIR spectroscopy has the advantage to allow an automated analysis that is an important 
criterion for a transposition of IR spectroscopy into a clinical application. This automation 
advantage can be seen in the time comparison with HT1FTIR being able to collect 360 spectra, 
in the same time it would allow to collect 40 spectra in the current ATR1FTIR approach. An 
automated approach for ATR1FTIR analysis would be beneficial as there is a comparable 
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spectral reproducibility between ATR1FTIR and HT1FTIR spectroscopy and a comparable 
ability to discriminate and illuminate differences in patient spectra but with an automated 
ATR1FTIR approach, there would not be a need for dilution. 
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
/

0 & Schematic methodology representation.  Dilution test study performed on human pooled 
serum by high throughput1Fourier transform infrared (HT1FTIR) spectroscopy and FTIR imaging. 1 
HT1FTIR and total attenuated reflection (ATR)1FTIR spectroscopy comparison study performed on 
pre1 (n=70) and post1 (n=35) surgery patient serum samples. Ge: germanium. 

0 (HT1FTIR raw spectra of non1diluted human pooled serum (blue), diluted samples (21fold: 
green; 31fold: red; 41fold: cyan; 51fold: black) and physiological water as negative control (pink).  

0'Variance study performed on HT1FTIR raw (A; B; C; D) and pre1processed (E; F; G; H) mean 
spectra (black) of diluted human pooled serum. Standard deviation is represented in grey. 

0 + Serum dilution study by FTIR imaging of dried drops. Original spectral images were 
atmospheric corrected. Other spectral images were reconstructed on a single wavenumber. Abs: 
absorbance
 
0.ATR1FTIR and HT1FTIR comparison study on pre and post1surgery serum samples.  
and  ATR1FTIR (A) and HT1FTIR (D) pre1processed mean spectra of patient serum prior to 
surgery in red and after surgery in blue. 1and ATR1FTIR (B) and HT1FTIR (E) PC1DFA 
scatter plot, pre1processed serum spectra of patients prior to surgery are represented by red 
triangles and after surgery by blue triangles over the spectral range of 95011200 cm11 with their 
respective 90% confidence ellipses. !andATR1FTIR (C) and HT1FTIR (F) corresponding
DF1 loading from whole patient serum. 2 HT1FTIR and ATR1FTIR spectra (from A and B) in 
red and green respectively. 
 
/

 &Quality test and variance study results performed on HT1FTIR spectra of normal pooled 
serum with different dilutions. 

(HT1FTIR and ATR1FTIRPC 1 loading peaks assignments.
1, 23, 24, 40, 41
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Fig. 1 Schematic methodology representation. A Dilution test study performed on human pooled serum by 
high throughput-Fourier transform infrared (HT-FTIR) spectroscopy and FTIR imaging. B HT-FTIR and total 
attenuated reflection (ATR)-FTIR spectroscopy comparison study performed on pre- (n=70) and post- (n=35) 
surgery patient serum samples. Ge: germanium. 
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Fig. 2 HT-FTIR raw spectra of non-diluted human 
pooled serum (blue), diluted samples (2-fold: green; 
3-fold: red; 4-fold: cyan; 5-fold: black) and 
physiological water as negative control (pink).  
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Dilution 
Right spectra after 
quality test (%) 
Mean STD              
(raw spectra) 
Mean STD                       
(pre-processed spectra) 
1/2 40 0, 015 0, 0004 
1/3 100 0, 0474 0, 0012 
1/4 100 0, 02 0, 0013 
1/5 90 0, 0342 0, 0022 
Table 1 Quality test and variance study results performed on HT-FTIR spectra of 
normal pooled serum with different dilutions. 
$Q
DO\
WLF
DO
0H
WKR
GV
$F
FH
SWH
G0
DQ
XV
FUL
SW
Pu
bl
ish
ed
 o
n 
23
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
tra
th
cl
yd
e o
n 
30
/0
3/
20
15
 1
5:
51
:0
4.
 
   
Fig. 3 Variance study performed on HT-FTIR raw (A; B; C; D) and pre-processed (E; F; G; H) mean spectra 
(black) of diluted human pooled serum. Standard deviation is represented in grey. 
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Fig. 4 Serum dilution study by FTIR imaging of dried drops. Original spectral images were atmospheric 
corrected. Other spectral images were reconstructed on a single wavenumber. Abs: absorbance. 
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Frequency (cm-1) Assignments 
1170  Ester C-0 asymmetric stretch 
1150 C-O stretch (carbohydrates) 
1125 C-C asymmetric stretch 
1110 CN stretch, CH bend 
1100 PO2¯ symmetric stretch (nucleic acid) 
1078 C-O stretch (deoxyribose/DNA-RNA) 
1065 Chain C-C 
1050 C-O stretch 
1023-1040 Glycogen 
1006 Phenylalanine (ring breathing) 
990 CO-O-C stretch 
970 C-C, CN stretch, PO3 
2-
 stretch (DNA) 
Table 2 HT-FTIR and ATR-FTIR PC 1 loading peaks 
assignments.1, 23, 24, 40, 41 
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